Snowball logo
logo
WPS_logo

West Pharmaceutical Services Inc

€347.60-€0.80  (0.23%)
Estimate
P/E
51.9
EPS
6.7
Beta
1.125
Growth
Revenue, YoY
16.85%
Net income, YoY
19.97%
FCF, YoY
-18.59%
Dividends
Dividend yield
0.2%
Annual payout
$0.78
Next ex. div date
October 29, 26
Payout
11.04%
Div.growth, 5y
5.51%
Dividend growth streak
9 y
Div.rating
About the company
Ticker
WPS
ISIN
US9553061055
Country
United States of America
Sector (GICS)
Healthcare
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Frequently asked questions

What sector does West Pharmaceutical Services Inc (WPS) operate in?

West Pharmaceutical Services Inc belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.

What is West Pharmaceutical Services Inc (WPS) current stock price?

As of the latest data, West Pharmaceutical Services Inc stock price is €347.60, with a previous close of €348.40. West Pharmaceutical Services Inc lost -€0.80 in the last trading session, representing a -0.23% loss.

What is West Pharmaceutical Services Inc (WPS) current market capitalization?

West Pharmaceutical Services Inc market cap is approximately 24.46 billion.

What is West Pharmaceutical Services Inc (WPS) Earnings Per Share (EPS)?

The trailing EPS is €6.70.

What is West Pharmaceutical Services Inc (WPS) Price-to-Earnings (P/E) ratio?

West Pharmaceutical Services Inc current P/E ratio is 51.88.

What is West Pharmaceutical Services Inc (WPS) EBITDA?

West Pharmaceutical Services Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 200.40 million.

Does West Pharmaceutical Services Inc (WPS) pay dividends?

Yes. West Pharmaceutical Services Inc pays quarterly dividends with an annualized yield of 0.2% and an estimated annual payout of €0.78 per share.

When is the next ex-dividend date for West Pharmaceutical Services Inc (WPS)?

The next ex-dividend date is scheduled for October 29, 2026.

When is West Pharmaceutical Services Inc (WPS) next earnings report?

West Pharmaceutical Services Inc is expected to release its next earnings report on September 30, 2026.

What is West Pharmaceutical Services Inc (WPS) beta (volatility) score?

West Pharmaceutical Services Inc has a beta of 1.125, meaning its volatility is roughly in line with the market.